BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Return 36.47%
This Quarter Return
+9.62%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$838M
AUM Growth
-$14.9M
Cap. Flow
-$24.6M
Cap. Flow %
-2.93%
Top 10 Hldgs %
68.16%
Holding
36
New
1
Increased
4
Reduced
2
Closed
3

Top Buys

1
THRD
Third Harmonic Bio
THRD
+$43.3M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$5.76M
3
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$2.94M
4
ANNX icon
Annexon
ANNX
+$2.23M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$164K

Top Sells

1
DVAX icon
Dynavax Technologies
DVAX
+$31.3M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$26M
3
RACB
Research Alliance Corp. II Class A Common Stock
RACB
+$9.8M
4
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
+$6.87M
5
PANA
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
+$4.88M

Sector Composition

1 Healthcare 97.33%
2 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IVVD icon
26
Invivyd
IVVD
$258M
$6.06M 0.72%
1,937,207
– –
ARYE
27
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.91M 0.59%
500,000
– –
BLSA
28
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$4.89M 0.58%
487,500
– –
NAUT icon
29
Nautilus Biotechnolgy
NAUT
$89.3M
$4.24M 0.51%
2,000,000
– –
SLDB icon
30
Solid Biosciences
SLDB
$408M
$3.7M 0.44%
528,661
– –
APTX
31
DELISTED
Aptinyx Inc. Common Stock
APTX
$3.27M 0.39%
8,891,758
– –
FLACU
32
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$3.05M 0.36%
300,000
– –
SYRE icon
33
Spyre Therapeutics
SYRE
$977M
$2.81M 0.34%
213,908
– –
ARYD
34
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-700,000
Closed -$6.87M
PANA
35
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
– –
-500,000
Closed -$4.88M
RACB
36
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
– –
-1,000,000
Closed -$9.8M
1
2